G9097 Onc diagnosis esophageal t4 no prog
Also known as: esophageal cancer T4, advanced esophageal cancer
Oncology diagnosis for esophageal cancer stage T4 involving adjacent structures without distant metastasis.
In Plain Language
advanced esophageal cancer; esophageal cancer involving nearby organs
Clinical Context
Used for locally advanced esophageal cancer with invasion into nearby structures, typically requiring multimodal therapy including neoadjuvant chemotherapy.
RVU Information
CPT G9097 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code G9097?
CPT G9097 (Onc diagnosis esophageal t4 no prog) is a G Codes code. Oncology diagnosis for esophageal cancer stage T4 involving adjacent structures without distant metastasis.
Who uses CPT code G9097?
CPT G9097 is used by Thoracic Surgery, Medical Oncology, Radiation Oncology. Used for locally advanced esophageal cancer with invasion into nearby structures, typically requiring multimodal therapy including neoadjuvant chemotherapy.
When is CPT G9097 used?
Used for locally advanced esophageal cancer with invasion into nearby structures, typically requiring multimodal therapy including neoadjuvant chemotherapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.